Intravenous Tocilizumab Versus Standard of Care in the Treatment of Severe and Critical COVID-19-Related Pneumonia: A Single Center, Double-Blind, Placebo Controlled, Phase 3 Trial . Acta Med Philipp 2024, 58 (6). https://doi.org/10.47895/amp.vi0.6175.